A carregar...
Sotagliflozin, an inhibitor of sodium–glucose cotransporters 1 and 2 (SGLT1/2), as a new therapeutic approach for patients with type 1 diabetes mellitus
Sotagliflozin (SOTA) is a dual inhibitor of SGLT1 and SGLT2 used in adults with type 1 diabetes. The mechanism of action, based on the inhibition of both the SGLT1 and SGLT2 cotransporters, allows simultaneous increase of glucose excretion and slowing down the absorption of glucose in the intestine....
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Kazimierz Wielki University
2018-12-01
|
| Colecção: | Journal of Education, Health and Sport |
| Assuntos: | |
| Acesso em linha: | http://www.ojs.ukw.edu.pl/index.php/johs/article/view/6378 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|